Findings indicate gut microbiome diversity changes precede rheumatoid arthritis, offering insights into microbial indicators for early disease detection.
Empress Therapeutics emerges with $50m to fund small molecule development – Pharmaceutical Technology
The Chemilogics platform benefits from a wealth of clinical data, and recent advances in genomics, AI and synthetic biology. Source: Shutterstock / metamorworks Life sciences